Extended Criteria Treatment for Liver Metastases With Heavy Tumour Burden

Status

Suspended

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512397-95-00

Enrollment

Registered

2024-07-15

Start date

2021-05-20

Completion date

Unknown

Last updated

2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Liver Metastases

Brief summary

Overall Survival at two years

Detailed description

Progression-free survival, Overall survival at 5 years, Resection/transplantation rate, Quality of life

Interventions

DRUGHEPARIN

DRUGDEXAMETHASONE

DRUGDEXAMETHASONE SODIUM PHOSPHATE

DRUGFloxuridine

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Overall Survival at two years	—

Secondary

Measure	Time frame
Progression-free survival, Overall survival at 5 years, Resection/transplantation rate, Quality of life	—

Countries

Norway

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026